Difference between revisions of "Archived Versions"

From QIBA Wiki
Jump to navigation Jump to search
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 +
{{TOCright}}
 
For current versions corresponding to these archived drafts, Follow the Committee link at the top of each section.
 
For current versions corresponding to these archived drafts, Follow the Committee link at the top of each section.
  
Line 4: Line 5:
  
 
===Advanced disease===
 
===Advanced disease===
 +
Full version of CT Volumetry Profile (archived now that streamlined version is posted):
 +
* [[Media:QIBA CTVol TumorVolumeChangeProfile TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
 +
:* Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
 +
:* Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
 +
 +
 +
'''2018'''
 +
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_DraftTechConfirmed-20180511-changetracked.docx | CT Tumor Volume Change Profile - Change tracked]] ''BALLOT DRAFT 2018.05.11''
 +
** This document shows all changes between the published Consensus Profile and the Ballot for Technically Confirmed.
 +
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20180405.pdf | QIBA Profile: CT Tumor Volume Change Profile]] ''post CONSENSUS 2018.04.05''
 +
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20180209.pdf | QIBA Profile: CT Tumor Volume Change Profile]] ''post CONSENSUS 2018.02.09''
 +
 +
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]
 +
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0.docx| Checklist - CT Tumor Volumetry for Advanced Disease]]
 +
 +
'''2017'''
 +
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_PostConsensus-20170403.docx | CT Tumor Volume Change Profile - PostConsensus]] ''DRAFT 2017.04.03''
 +
* '''[https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Results and Resolutions]'''
 +
:* Columbia Volume repeatability assessment
 +
::* [[Media:QIBA_CT_Volumetry_Field_Test_ACR_Phantom_Scan_Protocol.pdf| Columbia Scan Protocol]]
 +
* Incorporated during Feasibility Resolution:
 +
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0_DUKE+Notes2017.02.27.pdf | Duke feasibility results with committee notes]] 2017.02.27
 +
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-RUMC+Notes-20170306.docx| Rush feasibility results with committee notes]] 2017.03.06
 +
 +
'''2016'''
 +
* [[Invitation to Participate]] - Feasibility Testing
 +
 +
*'''[[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf | QIBA Profile: CT Tumor Volume Change Profile]]''' '''''CONSENSUS 2016.11.21b'''''
 +
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0.docx| Checklist - CT Tumor Volumetry for Advanced Disease]] ''Field Trial v1.0''
  
====2016====
 
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile_20161018.docx | QIBA Profile: CT Tumor Volume Change Profile]] ''18Oct2016''
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile_20161018.docx | QIBA Profile: CT Tumor Volume Change Profile]] ''18Oct2016''
  
Line 20: Line 49:
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile2016.02.13.docx | QIBA Profile: CT Tumor Volume Change Profile v.2.4]] ''13February2016''
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile2016.02.13.docx | QIBA Profile: CT Tumor Volume Change Profile v.2.4]] ''13February2016''
  
====2015====
+
'''2015'''
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile.doc|QIBA Profile: CT Tumor Volume Change Profile v.2.4]] ''3May2015''
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile.doc|QIBA Profile: CT Tumor Volume Change Profile v.2.4]] ''3May2015''
  
====2014====
+
'''2014'''
  
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile - Claim language - Merged20141027.doc|QIBA Profile: Tumor Volume Change Claim Language - Work in Progress]] ''29October2014''
 
*[[Media:QIBA_CVol_TumorVolumeChangeProfile - Claim language - Merged20141027.doc|QIBA Profile: Tumor Volume Change Claim Language - Work in Progress]] ''29October2014''
Line 37: Line 66:
 
*[[Media:QIBA CT Vol TumorVolumeChangeProfile (with additional compliance work) v2 3a 20 Jan 2014.doc|QIBA Profile: Tumor Change Profile v2.3a]] ''20January2014''
 
*[[Media:QIBA CT Vol TumorVolumeChangeProfile (with additional compliance work) v2 3a 20 Jan 2014.doc|QIBA Profile: Tumor Change Profile v2.3a]] ''20January2014''
  
====2013====
+
'''2013'''
 
*[[Media:QIBA CT Vol Tumor Volume Change, v2.3 10-31-2013.doc|QIBA Profile: CT Volumetry: Tumor Volume Change, v2.3 with rough compliance edits'']] '31October2013'
 
*[[Media:QIBA CT Vol Tumor Volume Change, v2.3 10-31-2013.doc|QIBA Profile: CT Volumetry: Tumor Volume Change, v2.3 with rough compliance edits'']] '31October2013'
  
====2012====
+
'''2012'''
 
*[[Media:QIBA Vol-CT AdvDisease v2.2 Profile DraftReviewed 08AUG2012.doc|QIBA Profile: CT Volumetry AdvDisease v2.2 Profile Draft]] ''(Current Profile Draft) 2012-08-08''
 
*[[Media:QIBA Vol-CT AdvDisease v2.2 Profile DraftReviewed 08AUG2012.doc|QIBA Profile: CT Volumetry AdvDisease v2.2 Profile Draft]] ''(Current Profile Draft) 2012-08-08''
  
Line 83: Line 112:
 
*[[Media:QIBA Vol-CT AdvDiseaseV2.0 Public Comment Resolution 2012.01.03.doc|QIBA Vol-CT AdvDiseaseV2.0 Public Comment Resolution 2012-01-03]] ''(Public Comments & Resolutions) 2012-01-03''
 
*[[Media:QIBA Vol-CT AdvDiseaseV2.0 Public Comment Resolution 2012.01.03.doc|QIBA Vol-CT AdvDiseaseV2.0 Public Comment Resolution 2012-01-03]] ''(Public Comments & Resolutions) 2012-01-03''
  
====2011====
+
'''2011'''
 
*[[:Media:QIBA_Vol-CT_AdvDiseaseV2.1_Profile_draft_2011.12.07.doc‎|QIBA_Vol-CT_AdvDiseaseV2.1_Profile_draft_2011.12.07.doc‎]] ''(Profile Draft) 2011-12-07''
 
*[[:Media:QIBA_Vol-CT_AdvDiseaseV2.1_Profile_draft_2011.12.07.doc‎|QIBA_Vol-CT_AdvDiseaseV2.1_Profile_draft_2011.12.07.doc‎]] ''(Profile Draft) 2011-12-07''
 
*[[Media:QIBA Vol-CT AdvDiseaseV2 0 Public Comment Resolution 2011-11-21.doc|QIBA Vol-CT AdvDiseaseV2 0 Public Comment Resolution 2011-11-21.doc]] ''(Public Comments & Resolutions) 2011-11-21''
 
*[[Media:QIBA Vol-CT AdvDiseaseV2 0 Public Comment Resolution 2011-11-21.doc|QIBA Vol-CT AdvDiseaseV2 0 Public Comment Resolution 2011-11-21.doc]] ''(Public Comments & Resolutions) 2011-11-21''
Line 99: Line 128:
 
* [[Media:2011.01.09.QIBA VIA Profile V1 5.doc|VIA Profile v1.5]] ''01/09/2011''
 
* [[Media:2011.01.09.QIBA VIA Profile V1 5.doc|VIA Profile v1.5]] ''01/09/2011''
  
====2010====
+
'''2010'''
 
*[[Media: 2010.09.09.UPICT_CT_Lung_Nodule_V1_4a.cleaner copy.doc|VIA Protocol v1.4]] ''Word version known as field test v1.0, 09-09-2010''
 
*[[Media: 2010.09.09.UPICT_CT_Lung_Nodule_V1_4a.cleaner copy.doc|VIA Protocol v1.4]] ''Word version known as field test v1.0, 09-09-2010''
 
*[[Media: 2010.09.09_UPICT_V1_4_1_FIELD_TEST.doc|VIA Protocol v1.4.1]] ''(Early field test protocol draft) 2010-09-09''
 
*[[Media: 2010.09.09_UPICT_V1_4_1_FIELD_TEST.doc|VIA Protocol v1.4.1]] ''(Early field test protocol draft) 2010-09-09''
  
====2009====
+
'''2009'''
 
*[[Media:Work breakdown for volCT-formatted.doc| Work Breakdown for Volumetric CT]] ''07.12.10''
 
*[[Media:Work breakdown for volCT-formatted.doc| Work Breakdown for Volumetric CT]] ''07.12.10''
 
*[[Media:2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors.long version.doc|2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors - long version]]
 
*[[Media:2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors.long version.doc|2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors - long version]]

Latest revision as of 21:43, 6 July 2022

For current versions corresponding to these archived drafts, Follow the Committee link at the top of each section.

CT Volumetry Biomarker Ctte

Advanced disease

Full version of CT Volumetry Profile (archived now that streamlined version is posted):

  • Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
  • Assessment Procedures (refer to Section 4 in the Profile document - pg 30)


2018

2017

  • Columbia Volume repeatability assessment
  • Incorporated during Feasibility Resolution:

2016

2015

2014

2013

2012

2011

2010

2009

fMRI tech ctte

FDG-PET tech ctte

Volumetric-CT tech ctte

COPD-Asthma tech ctte